Familial hypercholesterolaemia trials in Argentina

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Where

  Formosa

  Age

  2 years to 100 years

  People

  195 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT05682378
• Phase 3Taking people
  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Where

  Buenos Aires, CABA

  Age

  6 years to 11 years

  People

  60 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06597019
• Phase 4Taking people
  LATAM LOWERS LDL-C

  Where

  Corrientes

  Age

  18 years to 100 years

  People

  520 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06501443